Addex Therapeutics Ltd - Company Profile
Powered by 
All the sales intelligence you need on Addex Therapeutics Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Addex Therapeutics Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Addex Therapeutics Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Addex Therapeutics Ltd (Addex) is a biopharmaceutical company that focuses on the development of orally available, small molecule allosteric modulators for neurological disorders. The company’s strategic collaborations, focused R&D activities, and lead product: Dipraglurant extensive are its strengths. The company's financial instability and dependency on external funding could be a cause for concern to the company. The company could benefit from robust product pipeline, strategic agreement, growing market for epilepsy. However, its performance could be affected by competitive environment, stringent regulations, and cost containment pressures.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer